{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T02:13:41Z","timestamp":1779329621937,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T00:00:00Z","timestamp":1519084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Fapesp","doi-asserted-by":"crossref","award":["2013\/22331-5"],"award-info":[{"award-number":["2013\/22331-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CNPQ","award":["308111\/2013\/3"],"award-info":[{"award-number":["308111\/2013\/3"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00296-018-3997-1","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T04:34:06Z","timestamp":1519101246000},"page":"1043-1052","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Activation status of peripheral blood neutrophils and the complement system in adult rheumatoid arthritis patients undergoing combined therapy with infliximab and methotrexate"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2039-0897","authenticated-orcid":false,"given":"Larissa F.","family":"Marchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana B.","family":"Paoliello-Paschoalato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00ea D. R.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Elisa C. S.","family":"Azzolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana M.","family":"Kabeya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo A.","family":"Donadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yara Maria","family":"Lucisano-Valim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,20]]},"reference":[{"key":"3997_CR1","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365:2205\u20132219","journal-title":"N Engl J Med"},{"key":"3997_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nrrheum.2015.171","volume":"12","author":"IB McInnes","year":"2016","unstructured":"McInnes IB, Buckley CD, Isaacs JD (2016) Cytokines in rheumatoid arthritis\u2014shaping the immunological landscape. Nat Rev Rheumatol 12:63\u201368","journal-title":"Nat Rev Rheumatol"},{"key":"3997_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.smim.2016.03.004","volume":"28","author":"N Thieblemont","year":"2016","unstructured":"Thieblemont N, Wright HL, Edwards SW, Witko-Sarsat V (2016) Human neutrophils in auto-immunity. Semin Immunol 28:159\u2013173","journal-title":"Semin Immunol"},{"key":"3997_CR4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/art.10148","volume":"46","author":"American College of Rheumatology","year":"2002","unstructured":"American College of Rheumatology (2002) Guidelines for the management of rheumatoid arthritis\u20142002 update. Arthritis Rheum 46:328\u2013346","journal-title":"Arthritis Rheum"},{"key":"3997_CR5","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.clinthera.2011.05.044","volume":"33","author":"JR Curtis","year":"2011","unstructured":"Curtis JR, Singh JA (2011) The use of biologics in rheumatoid arthritis: current and emerging paradigms of care. Clin Ther 33:679\u2013707","journal-title":"Clin Ther"},{"key":"3997_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/rheumatology\/ket260","volume":"53","author":"M Jani","year":"2014","unstructured":"Jani M, Barton A, Warren RB, Griffiths CEM, Chinoy H (2014) The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases. Rheumatology 53:213\u2013222","journal-title":"Rheumatology"},{"key":"3997_CR7","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1007\/s00296-015-3366-2","volume":"35","author":"D Dimopoulou","year":"2015","unstructured":"Dimopoulou D (2015) Infliximab as a treatment option for patients with rheumatoid arthritis and primary biliary cirrhosis. Rheumatol Int 35:1913\u20131916","journal-title":"Rheumatol Int"},{"key":"3997_CR8","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.rbr.2014.10.009","volume":"55","author":"JO Costa","year":"2015","unstructured":"Costa JO, Lemos LLP, Machado MAA, Almeida AM, Kakehasi AM, Ara\u00fajo VE et al (2015) Infliximab, methotrexate and their combination for the treatment of rheumatoid arthritis: a systematic review and meta-analysis. Rev Bras Reumatol 55:146\u2013158","journal-title":"Rev Bras Reumatol"},{"issue":"suppl 2","key":"3997_CR9","doi-asserted-by":"publisher","first-page":"ii15","DOI":"10.1093\/rheumatology\/kew352","volume":"55","author":"Y Tanaka","year":"2016","unstructured":"Tanaka Y (2016) Stopping tumour necrosis factor-targeted biological DMARDs in rheumatoid arthritis. Rheumatology 55(suppl 2):ii15\u2013ii22","journal-title":"Rheumatology"},{"key":"3997_CR10","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.rbr.2015.08.004","volume":"55","author":"LM Mota","year":"2015","unstructured":"Mota LM, Cruz BA, Albuquerque CP, Gon\u00e7alves DP, Laurindo IM, Pereira IA et al (2015) Update on the 2012 Brazilian Society of Rheumatology Guidelines for the treatment of rheumatoid arthritis: position on the use of tofacitinib. Rev Bras Reumatol 55:512\u2013521","journal-title":"Rev Bras Reumatol"},{"key":"3997_CR11","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s10067-012-2146-6","volume":"32","author":"C Pomirleanu","year":"2013","unstructured":"Pomirleanu C, Ancuta C, Miu S, Chirieac R (2013) A predictive model for remission and low disease activity in patients with established rheumatoid arthritis receiving TNF blockers. Clin Rheumatol 32:665\u2013670","journal-title":"Clin Rheumatol"},{"key":"3997_CR12","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1093\/rheumatology\/kes383","volume":"52","author":"S Shaffu","year":"2013","unstructured":"Shaffu S, Edwards J, Neame R, Hassan W (2013) Self-assessment of 28-joint disease activity scores by patients with rheumatoid arthritis on anti-TNF therapy. Rheumatology 52:576\u2013578","journal-title":"Rheumatology"},{"key":"3997_CR13","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.autrev.2009.12.013","volume":"9","author":"R Casc\u00e3o","year":"2010","unstructured":"Casc\u00e3o R, Ros\u00e1rio HS, Souto-Carneiro MM, Fonseca JE (2010) Neutrophils in rheumatoid arthritis: more than simple final effectors. Autoimmun Rev 9:531\u2013535","journal-title":"Autoimmun Rev"},{"key":"3997_CR14","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1002\/eji.200939578","volume":"39","author":"DL Asquith","year":"2009","unstructured":"Asquith DL, Miller AM, McInnes IB, Liew FY (2009) Animal models of rheumatoid arthritis. Eur J Immunol 39:2040\u20132044","journal-title":"Eur J Immunol"},{"key":"3997_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.rdc.2010.03.004","volume":"36","author":"A Gierut","year":"2010","unstructured":"Gierut A, Perlman H, Pope RM (2010) Innate immunity and rheumatoid arthritis. Rheum Dis Clin N Am 36:271\u2013296","journal-title":"Rheum Dis Clin N Am"},{"key":"3997_CR16","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jaut.2009.11.014","volume":"34","author":"M Chen","year":"2010","unstructured":"Chen M, Daha MR, Kallenberg CG (2010) The complement system in systemic autoimmune disease. J Autoimmun 34:276\u2013286","journal-title":"J Autoimmun"},{"key":"3997_CR17","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s12026-013-8422-y","volume":"56","author":"E Ballanti","year":"2013","unstructured":"Ballanti E, Perricone C, Greco E, Ballanti M, Di Muzio G, Chimenti MS et al (2013) Complement and autoimmunity. Immunol Res 56:477\u2013491","journal-title":"Immunol Res"},{"key":"3997_CR18","doi-asserted-by":"publisher","first-page":"429878","DOI":"10.1155\/2015\/429878","volume":"2015","author":"AB Paoliello-Paschoalato","year":"2015","unstructured":"Paoliello-Paschoalato AB, Marchi LF, Andrade MF, Kabeya LM, Donadi EA, Lucisano-Valim YM (2015) Fc\u03b3 and complement receptors and complement proteins in neutrophil activation in rheumatoid arthritis: contribution to pathogenesis and progression and modulation by natural products. Evid Based Complement Alternat Med 2015:429878","journal-title":"Evid Based Complement Alternat Med"},{"key":"3997_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1876894601103010001","volume":"3","author":"AB Paoliello-Paschoalato","year":"2011","unstructured":"Paoliello-Paschoalato AB, Moreira MR, Azzolini AECS, Cavenaghi AA, Marzocchi-Machado CM, Donadi EA et al (2011) Activation of complement alternative pathway in rheumatoid arthritis: implications in peripheral neutrophils functions. Open Autoimmun J 3:1\u20139","journal-title":"Open Autoimmun J"},{"key":"3997_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Frie JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"3997_CR21","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1002\/1529-0131(199810)41:10<1845::AID-ART17>3.0.CO;2-K","volume":"41","author":"AM Gestel van","year":"1998","unstructured":"van Gestel AM, Haagsma CJ, van Riel PL (1998) Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 41:1845\u20131850","journal-title":"Arthritis Rheum"},{"key":"3997_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jim.2014.07.001","volume":"412","author":"AB Paoliello-Paschoalato","year":"2014","unstructured":"Paoliello-Paschoalato AB, Azzolini AECS, Cruz MFC, Marchi LF, Kabeya LM, Donadi EA et al (2014) Isolation of healthy individuals\u2019 and rheumatoid arthritis patients\u2019 peripheral blood neutrophils by the gelatin and Ficoll-Hypaque methods: comparative efficiency and impact on the neutrophil oxidative metabolism and Fc\u03b3 receptor expression. J Immunol Methods 412:70\u201377","journal-title":"J Immunol Methods"},{"issue":"5 Suppl 46","key":"3997_CR23","first-page":"S22","volume":"25","author":"M Dougados","year":"2007","unstructured":"Dougados M, Aletaha D, van Riel P (2007) Disease activity measures for rheumatoid arthritis. Clin Exp Rheumatol 25(5 Suppl 46):S22\u2013S29","journal-title":"Clin Exp Rheumatol"},{"key":"3997_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s12016-007-8017-2","volume":"34","author":"RD Oliveira","year":"2008","unstructured":"Oliveira RD, Junta CM, Oliveira FR, Silva LM, Donadi EA, Louzada-Junior P (2008) Share epitope, citrullinated cyclic peptide antibodies and smoking in Brazilian rheumatoid arthritis patients. Clinic Rev Allerg Immunol 34:32\u201335","journal-title":"Clinic Rev Allerg Immunol"},{"key":"3997_CR25","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1191\/0961203302lu172oa","volume":"11","author":"CM Marzocchi-Machado","year":"2002","unstructured":"Marzocchi-Machado CM, Alves CMOS, Azzolini AECS, Polizello ACM, Carvalho IF, Lucisano-Valim YM (2002) Fc\u03b3 and complement receptors: expression, role and cooperation to mediate the oxidative burst and degranulation of neutrophil of Brazilian SLE patients. Lupus 11:240\u2013248","journal-title":"Lupus"},{"key":"3997_CR26","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1084\/jem.115.3.453","volume":"115","author":"S Boyden","year":"1962","unstructured":"Boyden S (1962) The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med 115:453\u2013466","journal-title":"J Exp Med"},{"key":"3997_CR27","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1084\/jem.137.2.387","volume":"137","author":"SH Zigmond","year":"1973","unstructured":"Zigmond SH, Hirsch JG (1973) Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J Exp Med 137:387\u2013410","journal-title":"J Exp Med"},{"key":"3997_CR28","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.fct.2007.02.008","volume":"45","author":"AP Landi-Librandi","year":"2007","unstructured":"Landi-Librandi AP, Chrys\u00f3stomo TN, Azzolini AECS, Recchia CGV, Uyemura SA, Assis-Pandochi AI (2007) Effect of the extract of the tamarind (Tamarindus indica) fruit on the complement system: studies in vitro and in hamsters submitted to a cholesterol-enriched diet. Food Chem Toxicol 45:1487\u20131495","journal-title":"Food Chem Toxicol"},{"key":"3997_CR29","doi-asserted-by":"publisher","first-page":"e000009","DOI":"10.1136\/rmdopen-2014-000009","volume":"2","author":"D Aletaha","year":"2016","unstructured":"Aletaha D, Bl\u00fcml S (2016) Therapeutic implications of autoantibodies in rheumatoid arthritis. RMD Open 2:e000009","journal-title":"RMD Open"},{"key":"3997_CR30","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.3109\/10715762.2012.727991","volume":"46","author":"S Kundu","year":"2012","unstructured":"Kundu S, Ghosh P, Datta S, Ghosh A, Chattopadhyay S, Chatterjee M (2012) Oxidative stress as a potential biomarker for determining disease activity in patients with rheumatoid arthritis. Free Radic Res 46:1482\u20131489","journal-title":"Free Radic Res"},{"key":"3997_CR31","first-page":"232","volume":"30","author":"AA Broeder den","year":"2003","unstructured":"den Broeder AA, Wanten GJ, Oyen WJ, Naber T, van Riel PL, Barrera P (2003) Neutrophil migration and production of reactive oxygen species during treatment with a fully human anti-tumor necrosis factor-alpha monoclonal antibody in patients with rheumatoid arthritis. J Rheumatol 30:232\u2013237","journal-title":"J Rheumatol"},{"key":"3997_CR32","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.4049\/jimmunol.156.4.1646","volume":"156","author":"HM Lorenz","year":"1996","unstructured":"Lorenz HM, Antoni C, Valerius T, Repp R, Gr\u00fcnke M, Schwerdtner N et al (1996) In vivo blockade of TNF-\u03b1 by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects. J Immunol 156:1646\u20131653","journal-title":"J Immunol"},{"key":"3997_CR33","first-page":"89","volume":"26","author":"S Wijngaarden","year":"2008","unstructured":"Wijngaarden S, van de Winkel JG, Bijlsma JW, Lafeber FP, van Roon JA (2008) Treatment of rheumatoid arthritis patients with anti-TNF-\u03b3 monoclonal antibody is accompanied by down-regulation of the activating Fc\u03b3 receptor I on monocytes. Clin Exp Rheumatol 26:89\u201395","journal-title":"Clin Exp Rheumatol"},{"key":"3997_CR34","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/art.23200","volume":"58","author":"K Belostocki","year":"2008","unstructured":"Belostocki K, Pricop L, Redecha PB, Aydin A, Leff L, Harrison MJ et al (2008) Infliximab treatment shifts the balance between stimulatory and inhibitory Fc\u03b3 receptor type II isoforms on neutrophils in patients with rheumatoid arthritis. Arthritis Rheum 58:384\u2013388","journal-title":"Arthritis Rheum"},{"key":"3997_CR35","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/art.10183","volume":"46","author":"E Neumann","year":"2002","unstructured":"Neumann E, Barnum SR, Tarner IH, Echols J, Fleck M, Judex M et al (2002) Local production of complement proteins in rheumatoid arthritis synovium. Arthritis Rheum 46:934\u2013945","journal-title":"Arthritis Rheum"},{"key":"3997_CR36","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.imbio.2012.07.013","volume":"217","author":"KE Happonen","year":"2012","unstructured":"Happonen KE, Heinegard D, Saxne T, Blom AM (2012) Interactions of the complement system with molecules of extracellular matrix: relevance for joint diseases. Immunobiology 217:1088\u20131096","journal-title":"Immunobiology"},{"key":"3997_CR37","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nm0395-237","volume":"1","author":"R Malhotra","year":"1995","unstructured":"Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB (1995) Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med 1:237\u2013243","journal-title":"Nat Med"},{"key":"3997_CR38","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1002\/art.24622","volume":"60","author":"LA Trouw","year":"2009","unstructured":"Trouw LA, Haisma EM, Levarht EW, van der Woude D, Ioan-Facsinay A, Daha MR et al (2009) Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways. Arthritis Rheum 60:1923\u20131931","journal-title":"Arthritis Rheum"},{"key":"3997_CR39","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1749-6632.1982.tb22140.x","volume":"389","author":"JE Volanakis","year":"1982","unstructured":"Volanakis JE (1982) Complement activation by C-reactive protein complexes. Ann N Y Acad Sci 389:235\u2013250","journal-title":"Ann N Y Acad Sci"},{"key":"3997_CR40","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/1529-0131(200105)44:5<997::AID-ANR178>3.0.CO;2-C","volume":"44","author":"ET Molenaar","year":"2001","unstructured":"Molenaar ET, Voskuyl AE, Familian A, van Mierlo GJ, Dijkmans BA, Hack CE (2001) Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein. Arthritis Rheum 44:997\u20131002","journal-title":"Arthritis Rheum"},{"key":"3997_CR41","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/ard.2004.029124","volume":"64","author":"A Familian","year":"2005","unstructured":"Familian A, Voskuyl AE, van Mierlo GJ, Heijst HA, Twisk JW, Dijkmans BA et al (2005) Infliximab treatment reduces complement activation in patients with rheumatoid arthritis. Ann Rheum Dis 64:1003\u20131008","journal-title":"Ann Rheum Dis"},{"key":"3997_CR42","doi-asserted-by":"crossref","first-page":"473","DOI":"10.4049\/jimmunol.157.1.473","volume":"157","author":"GJ Wolbink","year":"1996","unstructured":"Wolbink GJ, Brouwer MC, Buysmann S, ten Berge IJ, Hack CE (1996) CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes. J Immunol 157:473\u2013479","journal-title":"J Immunol"},{"issue":"Suppl 2","key":"3997_CR43","first-page":"S92","volume":"58","author":"MJ Elliot","year":"2008","unstructured":"Elliot MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katasikis P et al (2008) Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum 58(Suppl 2):S92\u2013S101","journal-title":"Arthritis Rheum"},{"key":"3997_CR44","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/art.1780341209","volume":"34","author":"JP Brodeur","year":"1991","unstructured":"Brodeur JP, Ruddy S, Schwartz LB, Moxley G (1991) Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis. Arthritis Rheum 34:1531\u20131537","journal-title":"Arthritis Rheum"},{"key":"3997_CR45","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3390\/ijms18020293","volume":"18","author":"M Franco Di","year":"2017","unstructured":"Di Franco M, Lucchino B, Spaziante M, Iannuccelli C, Valesini G, Iaiani G (2017) Lung infections in systemic rheumatic disease: focus on opportunistic infections. Int J Mol Sci 18:293","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3997_CR46","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s10067-007-0768-x","volume":"27","author":"CMOS Alves","year":"2008","unstructured":"Alves CMOS, Marzocchi-Machado CM, Louzada-Junior P, Azzolini AECS, Polizello ACM, Carvalho IF, Lucisano-Valim YM (2008) Superoxide anion production by neutrophils is associated with prevalent clinical manifestations in systemic lupus erythematosus. Clin Rheumatol 27:701\u2013708","journal-title":"Clin Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-018-3997-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-3997-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-3997-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T04:40:55Z","timestamp":1693543255000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-018-3997-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,20]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["3997"],"URL":"https:\/\/doi.org\/10.1007\/s00296-018-3997-1","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,20]]},"assertion":[{"value":"17 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Research Ethics Committee of the Ribeir\u00e3o Preto Medical School Hospital of the University of S\u00e3o Paulo (HC-FMRP-USP, Ribeir\u00e3o Preto, SP, Brazil) approved the study protocol (HCRP n. 10097\/2002).\u00a0All the procedures conducted in humans complied with\u00a0Resolution 466\/12 of the Brazilian National Health Council, which\u00a0follows the recommendations\u00a0of\u00a0the\u00a01964 Helsinki declaration and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All the patients and healthy subjects signed the informed consent form to participate in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}